|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-3
|
|
pubmed:abstractText |
hereditary angioedema (HAE) is a rare disorder characterized by a quantitative or functional deficiency of C1 esterase inhibitor (C1-INH), resulting in periodic attacks of acute edema at various body locations. The symptoms of these painful attacks can be treated effectively with C1-INH concentrate.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1534-4436
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
62-8
|
|
pubmed:dateRevised |
2011-5-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21195947-Abdomen,
pubmed-meshheading:21195947-Acute Disease,
pubmed-meshheading:21195947-Adolescent,
pubmed-meshheading:21195947-Adult,
pubmed-meshheading:21195947-Angioedemas, Hereditary,
pubmed-meshheading:21195947-Child,
pubmed-meshheading:21195947-Complement C1 Inhibitor Protein,
pubmed-meshheading:21195947-Face,
pubmed-meshheading:21195947-Female,
pubmed-meshheading:21195947-Humans,
pubmed-meshheading:21195947-Male,
pubmed-meshheading:21195947-Middle Aged,
pubmed-meshheading:21195947-Prospective Studies,
pubmed-meshheading:21195947-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks.
|
|
pubmed:affiliation |
DallasAllergyImmunology, Dallas, Texas 75230, USA. richwasserman_pdai@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
